Ersin KILINÇ, Nesrin HAŞİMİ, Özlem DEMİRCİ, Veysel TOLAN

C60 Fullerene-γ-Fe2O3 ve Çok Duvarlı Karbon Nanotüpler-γ-Fe2O3 Nanopartiküllerinin Genotoksik Etkilerinin Değerlendirilmesi

Nanotıp uygulamalarında manyetik nano parçacıkların kullanılması son yıllarda önemli ölçüde artmıştır. Bu amaçla kullanılan nano malzemelerin genotoksik değerlendirilmesi bu nedenle çok önemlidir. Çalışmamızda, C60 fullerene-γ-Fe2O3 ve çok duvarlı karbon nanotüpler γ-Fe2O3 manyetik nanopartiküllerin geniş bir konsantrasyon aralığında (0.1, 1.0, 5.0, 10.0, 25.0, 50.0 ve 100.0 µg/plaka) genotoksik etkisi Bakteriyel Geri Mutasyon Testi kullanılarak araştırıldı. Bu manyetik nanopartiküller, metabolik aktivasyonun varlığında ve yokluğunda Salmonella typhimurium TA100 ve TA98’de genetik hasara neden olmamıştır. Günlük yaşamlarımızda nanopartiküllerin varlığındaki hızlı artış nedeniyle, nanopartiküller ile ilgili mutajenite ve toksisite verileri oldukça değerlidir. Bu nedenle, bu bileşiklerin etkili bir şekilde değerlendirilmesine olanak sağlayan in vivo ve in vitro çalışmalar oldukça önemlidir.

Evaluation of Genotoxic Effects of C60 Fullerene-γ-Fe2O3 and MultiWall Carbon Nanotubes-γ-Fe2O3 Nanoparticles

The use of magnetic nanoparticles in nanomedicine applications has increased significantly in recent years. Genotoxic evaluation ofthe nanomaterials used for this purpose is therefore very important. In our study, the genotoxic effect of C60 fullerene-γ-Fe2O3 andmulti-wall carbon nanotubes-γ-Fe2O3 magnetic nanoparticles over a wide concentration range (0.1, 1.0, 5.0, 10.0, 25.0, 50.0, and 100.0µg/plate) was investigated using the Bacterial Reverse Mutation Test. These magnetic nanoparticles did not cause genetic damage toSalmonella typhimurium TA100 and TA98 in the presence and absence of metabolic activation. Due to the rapid increase in the presenceof nanoparticles in our daily lives, mutagenicity and toxicity data related to nanoparticles are quite valuable. For this reason, in vivo andin vitro studies that allow for effective evaluation of these compounds is of the utmost importance.

PDF

___

Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM: Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett, 171 (3): 99-110, 2007. DOI: 10.1016/j.toxlet.2007.04.008
Shinohara N, Matsumoto K, Endoh S, Maru J, Nakanishi J: In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles. Toxicol Lett, 191 (2-3): 289-296, 2009. DOI: 10.1016/j.toxlet.2009.09.012
Shimizu K, Kubota R, Kobayashi N, Tahara M, Sugimoto N, Nishimura T, Ikarashi Y: Cytotoxic effects of hydroxylated fullerenes in three types of liver cells. Materials, 6 (7): 2713-2722, 2013. DOI: 10.3390/ ma6072713
Prylutska SV, Matyshevska OP, Golub AA, Prylutskyy YI, Potebnya GP, Ritter U, Scharff P: Study of C60 fullerenes and C60-containing composites cytotoxicity in vitro. Mater Sci Eng C Mater Biol Appl, 27, 1121- 1124, 2007. DOI: 10.1016/j.msec.2006.07.009
Tsuchiya T, Yamakoshi YN, Miyata N: A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem Biophys Res Commun, 206 (3): 885-894, 1995. DOI: 10.1006/bbrc.1995.1126
Mori T, Takada H, Ito S, Matsubayashi K, Miwa N, Sawaguchi T: Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology, 225 (1): 48-54, 2006. DOI: 10.1016/j.tox.2006.05.001
Partha R, Conyers JL: Biomedical applications of functionalized fullerene-based nanomaterials. Int J Nanomedicine, 4, 261-275, 2009. DOI: 10.2147/IJN.S5964
Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, Bonn GK: Medicinal applications of fullerenes. Int J Nanomedicine, 2 (4): 639-649, 2007.
Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, Zhao Y, Guo X: Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol, 39 (5): 1378-1383, 2005. DOI: 10.1021/es048729l
Brown DM, Donaldson K, Borm PJ, Schins RP, Dehnhardt M, Gilmour P, Jimenez LA, Stone V: Calcium and ROS-mediated activation of transcription factors and TNF-α cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol, 286 (2): L344-L353, 2004. DOI: 10.1152/ajplung.00139.2003
Oberdörster G, Oberdörster E, Oberdörster J: Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect, 113 (7): 823-839, 2005. DOI: 10.1289/ehp.7339
Schins RPF, Knaapen AM: Genotoxicity of poorly soluble particles. Inhal Toxicol, 19 (Suppl.1): 189-198, 2007. DOI: 10.1080/08958370701496202
Donaldson K, Poland CA: Nanotoxicity: Challenging the myth of nano-specific toxicity. Curr Opin Biotechnol, 24 (4): 724-734, 2013. DOI: 10.1016/j.copbio.2013.05.003
Buzea C, Pacheco II, Robbie K: Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases, 2 (4): MR17-MR71, 2007. DOI: 10.1116/1.2815690
Porter AE, Muller K, Skepper J, Midgley P, Welland M: Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: Studied by high resolution electron microscopy and electron tomography. Acta Biomater, 2 (4): 409-419, 2006. DOI: 10.1016/j. actbio.2006.02.006
Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P: Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect, 113 (11): 1555-1560, 2005. DOI: 10.1289/ehp.8006
Peters A, Veronesi B, Calderón-Garcidueñas L, Gehr P, Chen LC, Geiser M, Reed W, Rothen-Rutishauser B, Schürch S, Schulz H: Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol, 3:13, 2006. DOI: 10.1186/1743- 8977-3-13
Armentano I, Arciola CR, Fortunati E, Ferrari D, Mattioli S, Amoroso CF, Rizzo J, Kenny JM, Imbriani M, Visai L: The interaction of bacteria with engineered nanostructured polymeric materials: a review. ScientificWorldJournal, 2014:410423, 2014. DOI: 10.1155/2014/410423
McShan D, Ray PC, Yu H: Molecular toxicity mechanism of nanosilver. J Food Drug Anal, 22 (1): 116-127, 2014. DOI: 10.1016/j.jfda. 2014.01.010
Tran C, Hankin SM, Ross B, Aitken RJ, Jones AD, Donaldson K, Stone V, Trantra R: An outline scoping study to determine whether high aspect ratio nanoparticles (HARN) should raise the same concerns as do asbestos fibres. Report on project CB0406, 2008.
Szendi K, Varga C: Lack of genotoxicity of carbon nanotubes in a pilot study. Anticancer Res, 28, 349-352, 2008.
Alexiou C, Jurgons R, Seliger C, Iro H: Medical applications of magnetic nanoparticles. J Nanosci Nanotechnol, 6, 2762-2768, 2006. DOI: 10.1166/jnn.2006.464
Negi PS, Jayaprakash GK, Jena BS: Antioxidant and antimutagenic activities of pomegranate peel extracts. Food Chem, 80, 393-397, 2003. DOI: 10.1016/S0308-8146(02)00279-0
Di Sotto A, Chiaretti M, Carru GA, Bellucci S, Mazzanti G: Multiwalled carbon nanotubes: Lack of mutagenic activity in the bacterial reverse mutation assay. Toxicol Lett, 184 (3): 192-197, 2009. DOI: 10.1016/j. toxlet.2008.11.007
Maron DM, Ames BN: Revised methods for the Salmonella mutagenicity test. Mutat Res, 113, 173-215, 1983. DOI: 10.1016/0165-1161 (83)90010-9
Ames BN, Lee FD, Durston WE: An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci U S A, 70 (3): 782-786, 1973. DOI: 10.1073/pnas.70.3.782
Kılınç E: γ-Fe2O3 magnetic nanoparticle functionalized with carboxylated multi walled carbon nanotube: Synthesis, characterization, analytical and biomedical application. J Magn Magn Mater, 401, 949-955, 2016. DOI: 10.1016/j.jmmm.2015.11.003
Jarvis AS, Honeycutt ME, McFarland VA, Bulich AA, Bounds HC: A comparison of the Ames assay and Mutatox in assessing the mutagenic potential of contaminated dredged sediment. Ecotoxicol Environ Saf, 33 (2): 193-200, 1996. DOI: 10.1006/eesa.1996.0025
Devlin TM: Textbook of Biochemistry with Clinical Correlations. 2006.
Osugi ME, Rajeshwar K, Ferraz ERA, de Oliveira DP, Araújo ÂR, Zanoni MVB: Comparison of oxidation efficiency of disperse dyes by chemical and photoelectrocatalytic chlorination and removal of mutagenic activity. Electrochim Acta, 54 (7): 2086-2093, 2009. DOI: 10.1016/j.electacta.2008.07.015
Co-operation OfE, Development: Test No. 471: Bacterial Reverse Mutation Test. OECD Publishing, 1997.
Franchi LP, Manshian BB, de Souza TAJ, Soenen SJ, Matsubara EY, Rosolen JM, Takahashi CS: Cyto-and genotoxic effects of metallic nanoparticles in untransformed human fibroblast. Toxicol In Vitro, 29 (7): 1319-1331, 2015. DOI: 10.1016/j.tiv.2015.05.010
Ito A, Shinkai M, Honda H, Kobayashi T: Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng, 100 (1): 1-11, 2005. DOI: 10.1263/jbb.100.1
Naya M, Kobayashi N, Endoh S, Maru J, Honda K, Ema M, Tanaka J, Fukumuro M, Hasegawa K, Nakajima M, Hayashi M, Nakanishi J: In vivo genotoxicity study of single-wall carbon nanotubes using comet assay following intratracheal instillation in rats. Regul Toxicol Pharmacol, 64 (1): 124-129, 2012. DOI: 10.1016/j.yrtph.2012.05.020
Ema M, Imamura T, Suzuki H, Kobayashi N, Naya M, Nakanishi J: Evaluation of genotoxicity of multi-walled carbon nanotubes in a battery of in vitro and in vivo assays. Regul Toxicol Pharmacol, 63 (2): 188-195, 2012. DOI: 10.1016/j.yrtph.2012.03.014
Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE: Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett, 155 (3): 377-384, 2005. DOI: 10.1016/j.toxlet. 2004.11.004
Gupta AK, Gupta M: Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 26 (18): 3995- 4021, 2005. DOI: 10.1016/j.biomaterials.2004.10.012
Namdeo M, Saxena S, Tankhiwale R, Bajpai M, Mohan YM, Bajpai SK: Magnetic nanoparticles for drug delivery applications. J Nanosci Nanotechnol, 8 (7): 3247-3271, 2008. DOI: 10.1166/jnn.2008.399
Pan X, Redding JE, Wiley PA, Wen L, McConnell JS, Zhang B: Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay. Chemosphere, 79 (1): 113-116, 2010. DOI: 10.1016/ j.chemosphere.2009.12.056
Kılınç E: Fullerene C60 functionalized γ-Fe2O3 magnetic nanoparticle: Synthesis, characterization, and biomedical applications. Artif Cells Nanomed Biotechnol, 44 (1): 298-304, 2016. DOI: 10.3109/21691401. 2014.948182
Ghaffri Chanzanagh E, Seifdavati J, Gheshlagh FMA, Benamar HA, Sharifi RS: Effect of ZnO nanoparticles on in vitro gas production of some animal and plant protein sources. Kafkas Univ Vet Fak Derg, 24 (1): 25-32, 2018. DOI: 10.9775/kvfd.2017.18187
Kim JS, Lee K, Lee YH, Cho HS, Kim KH, Choi KH, Lee SH, Song KS, Kang CS, Yu IJ: Aspect ratio has no effect on genotoxicity of multi-wall carbon nanotubes. Arch Toxicol, 85 (7): 775-786, 2011. DOI: 10.1007/ s00204-010-0574-0